52
Participants
Start Date
February 28, 2003
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
epirubicin
50mg/m2 IV day 1
cisplatin
60mg/m2 IV day 1
5-fluorouracil
5-FU 200mg/m2/d IV 21 day continuous infusion Cont. infusional 5-FU 225mg/m2/day, 7 days/wk throughout entire period RT via CADD pump through PICC line
Radiotherapy
45Gy 25 Fractions, 5 days/week for 5 weeks
Liverpool Hospital, Liverpool
Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital, Sydney
Royal North Shore Hospital, Sydney
Westmead Hospital, Sydney
Calvary Mater Newcastle, Newcastle
Nepean Cancer Care Centre, Penrith
Austin Health, Melbourne
Alfred Hospital, Prahran
Andrew Love Cancer Care Centre, Geelong Hospital, Geelong
Royal Brisbane Hospital, Herston
Princess Alexandra Hospital, Woolloongabba
East Coast Cancer Centre, Tugun
Christchurch Hospital, Christchurch
Sir Charles Gairdner Hospital, Perth
Launceston General Hospital, Launceston
Peter MacCallum Cancer Centre, Melbourne
Mater QRI, Brisbane
Box Hill Hospital, Box Hill
The Royal Australian and New Zealand College of Radiologists
OTHER
Trans Tasman Radiation Oncology Group
OTHER